The Dupuytren's Disease Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for Dupuytren's disease has seen considerable growth recently. The value of the market is set to increase from $4.28 billion in 2024 to $4.55 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.3%.
The Dupuytren's Disease market is projected to grow to $5.76 billion by 2029, with a compound annual growth rate (CAGR) of 6.0%.
Download Your Free Sample of the 2025 Dupuytren's Disease Market Report and Uncover Key Trends Now!The key drivers in the dupuytren's disease market are:
• Advancements in treatment options for Dupuytren's disease
• Increased awareness and early diagnosis of the disease
• Growing healthcare expenditure worldwide
• Expansion of research and development in minimally invasive procedures
The dupuytren's disease market covered in this report is segmented –
1) By Disease Type: Type I, Type II, Type III
2) By Treatment: Surgery, Radiation Therapy, Needle Aponeurotomy, Steroid Shot, Enzyme Injection, Occupational Therapy, Other Treatments
3) By Route of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Diagnosis: Physical Examination, X-Ray, Other Diagnosis
5) By End-User: Hospitals, Clinics, Academic And Research Institute, Other End-Users
Subsegments:
1) By Type I: Classical Dupuytren’s Disease, Familial Dupuytren’s Disease
2) By Type II: Palmar Fasciitis, Ledderhose Disease
3) By Type III: Garrod’s Pads, Peyronie’s Disease
The key trends in the dupuytren's disease market are:
• Advancements in gene therapy are increasingly shaping the future of the Dupuytren's Disease Market.
• The market is experiencing a significant shift towards regenerative medicine and stem cell therapy.
• AI-driven diagnostic tools are becoming an important trend in the market.
• The industry is being influenced by the development in 3D printing for custom orthotics and minimally invasive surgical techniques.
Major players in the dupuytren's disease market are:
• Pfizer Inc.
• Aetna Inc.
• Mayo Clinic
• Penn Medicine
• Mercy Health
• Endo Inc.
• Resilience Orthopedics
• Raleigh Orthopaedic
• Hoag Orthopedic Institute
• OSS Health
• Connext Inc.
• University of Utah Health
• Ventoux Biosciences Inc.
• Auxilium Pharmaceuticals
• 180 Life Sciences Corp.
• Brigid Freyne MD
• Nantong Jinghua Pharmaceutical Co. Ltd.
• Sumitomo Dainippon Pharma Co. Ltd.
• Actiza Pharmaceutical Private Limited
• Spear Pharmaceuticals
North America was the largest region in the dupuytren's disease market in 2024